answer text |
<p>Antimicrobial resistance (AMR) is growing, presenting huge costs to both society
and the global economy – it is estimated that AMR will have a cumulative cost of $100
trillion by 2050. One of the main issues driving the increase in AMR is a market failure
preventing enough new antibiotic drugs from getting to market. The United Kingdom
sees the G20 as the best forum to discuss this economic issue and take action. The
UK is calling for the G20 to look at how it can put in place innovative financing
mechanisms to reinvigorate the antimicrobial development pipeline and help rectify
this market failure.</p>
|
|